PRUNUS Therapeutics is a Chicagoland-based biotech startup launched in 2016. PRUNUS’ main platform focuses on sustainable cancer therapeutics via synthetic biology. 



Our vision is to promote sustainable healthcare options for anyone in need to get back to normal life.


PRUNUS is developing new therapeutic approaches that may dramatically improve treatment outcome and quality of life by harnessing the power of body’s defense system.